Appropriate Use Criteria for ¹⁸F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease

J Nucl Med. 2017 Dec;58(12):2026-2037. doi: 10.2967/jnumed.117.197988. Epub 2017 Oct 12.

Authors

Affiliations

¹ Society of Nuclear Medicine and Molecular Imaging (SNMMI) [email protected].
² American College of Nuclear Medicine (ACNM).
³ European Association of Nuclear Medicine (EANM).
⁴ Society of Nuclear Medicine and Molecular Imaging (SNMMI).
⁵ Society for Pediatric Radiology (SPR); and.
⁶ Canadian Association of Nuclear Medicine (CANM).
⁷ American Society of Clinical Oncology (ASCO).

PMID: 29025980
DOI: 10.2967/jnumed.117.197988

No abstract available

MeSH terms

Fluorodeoxyglucose F18*
Humans
Neoplasm Staging
Neoplasms / diagnostic imaging*
Neoplasms / pathology*
Neoplasms / therapy
Positron Emission Tomography Computed Tomography*
Treatment Outcome

Substances

Fluorodeoxyglucose F18